Faheem Hasnain - Mar 20, 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
President & CEO, Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Mar 20, 2023
Transactions value $
$1,000,389
Form type
4
Date filed
3/22/2023, 05:14 PM
Previous filing
Jan 24, 2023
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Purchase $174K +169K +4.66% $1.03 3.79M Mar 20, 2023 By family trust F1
transaction GOSS Common Stock Purchase $322K +269K +7.12% $1.20 4.06M Mar 21, 2023 By family trust F2
transaction GOSS Common Stock Purchase $504K +441K +10.86% $1.14 4.5M Mar 22, 2023 By family trust F3
holding GOSS Common Stock 143K Mar 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +545K $0.00 545K Mar 20, 2023 Common Stock 545K $1.21 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.97 to 1.09 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F2 This transaction was executed in multiple trades at prices ranging from $1.155 to $1.21 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F3 This transaction was executed in multiple trades at prices ranging from $1.06 to $1.20 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F4 25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.